Newsquawk Logo

Evotec (EVT GY) announced it expects to receive approximately USD 100mln in upfront consideration upon closing of the sale of Tubulis to Gilead Sciences (GILD)

Evotec's announcement regarding the $100 million upfront consideration from the sale of Tubulis to Gilead is significant as it reflects a strategic divestment that could bolster Evotec's liquidity and focus on core operations.

Newsquawk StaffPublished On the live feed at — 5 more headlines followed before this page went public
Newsquawk headlinesUTC

US Redbook YoY (Apr/04) Y/Y 7.6%

An Israeli source told i24NEWS that even at this stage, the assessment in Israel is that there will be no breakthrough in the negotiations between the US and Iran

Evotec (EVT GY) announced it expects to receive approximately USD 100mln in upfront consideration upon closing of the sale of Tubulis to Gilead Sciences (GILD)

Communication with Iran is ongoing and intensive efforts are being made to bring both sides to the negotiating table, Al Mayadeen reports citing sources

Fed's Williams (voter) thinks Iran will go directly into headline inflation given energy; inflation this year should be around 2.75%

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

For Gilead, this acquisition enhances its biotechnology portfolio, potentially impacting its growth trajectory positively. As such, market sentiment could drive positive momentum for both companies' equities, while also influencing sector-related stocks in biotechnology and pharmaceuticals.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.